Check out the latest quotes April 15, Huahan bio-pharmaceutical with a total of 2.67 per share of the allocation of up to 265 million shares, to raise 707 million yuan, this morning to duplicate the card. Huahan biopharmaceutical (00587) issued a notice saying that in the old and new way, according to the best possible benchmark, a total of $2.67 per share will be allocated up to 265 million shares, accounting for about 16.63% of the enlarged share capital, 707 million yuan and a net amount of about 693 million yuan, to be used for the development of biopharmaceutical products and general operating capital. The selling price of $2.67 is about 11.88% of the discount of $3.03 before suspension. After the placement, the shareholding of Chairman Yue and Executive director Deng Jie was reduced from about 33.98% to about 28.33%. Huahan biopharmaceutical this morning.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
